The benchmark Nikkei share average closed 0.03% down to 23,290.86, after closing 1.35% firmer on Tuesday as nearly one-third of sector sub-indexes on the Tokyo Stock Exchange fell
Japanese shares closed flat on Wednesday as investors chose to book profit after the Nikkei briefly rebounded to pre-pandemic levels in the previous session, while a weaker yen and sustained hopes for COVID-19 treatment supported overall sentiment.
The benchmark Nikkei share average ended down 0.03% to 23,290.86, after closing 1.35% firmer on Tuesday. It hit its highest level since Feb. 21 in the last session, as investors cheered signs that researchers might be closer to a treatment for the coronavirus.
The broader Topix dipped 0.05% to 1,624.48.
Nearly one-third of the 33 sector sub-indexes on the Tokyo Stock Exchange fell, with textiles, real estate and foods leading declines.
A weakening yen helped markets trim losses, with the yen last traded down 0.01% at 106.415 per dollar.
A gainer was heavyweight SoftBank Group, up 3.39%, rising for a second straight session.
While investors are keenly watching Federal Reserve Chair Jerome Powell’s speech on Thursday for clues on the U.S. central bank’s view on inflation and monetary policy and also waiting for details on the health of Japanese Prime Minister Shinzo Abe.
Amid worries about his ability to continue as premier, local media reported that Abe plans to hold a press conference as early as this week about his health after recent visits to a hospital.
Fast-food restaurant group Colowide Co rose 2.73% as the company extended its hostile bid for casual dining chain Ootoya Holdings after failing to secure enough shares by the deadline. Ootoya shares jumped 9.41%.
Recruitment advertiser Recruit Holdings Co fell 1.44% ahead of its results after market hours.
The articles are for information purposes only and Precise Investors shall not be held responsible for any errors, omissions or inaccuracies within it. Any rules or regulations mentioned within the website are those relevant at the time of publication and may not be the most up-to-date.
Precise Investors does not endorse any of the products or services that appear on it or are linked to it and are not liable for any action that you may take as a result of the content of this website, or losses or damage you may incur doing so.
There is no obligation to purchase anything but, if you decide to do so, you are strongly advised to consult a professional adviser before making any investment decisions.
Please remember that investments of any type may rise or fall and past performance does not guarantee future performance in respect of income or capital growth; you may not get back the amount you invested.